JCR will continue to provide and collect pharmaceutical
information through Medical Representative
to promote the proper use of our products
and be trusted by medical professionals.
We aim to contribute to health and medicine improvements
by providing better treatment options
to medical professionals and patients.
Business Area |
Product Name |
Indication |
Growth hormone |
GROWJECT® |
Therapeutic product for growth hormone deficiency and short stature |
Lysosomal disease |
IZCARGO® |
Therapeutic product for Mucopolysaccharidosis type II |
Agalsidase Beta BS I.V. Infusion [JCR]※1 |
Therapeutic product for Fabry disease |
Regenerative medical products |
TEMCELL®HS Inj. |
Therapeutic product for acute graft-versus-host disease |
Renal anemia |
Epoetin Alfa BS Injection JCR ※2 |
Therapeutic product for renal anemia |
Darbepoetin Alfa BS Injection JCR ※2 |
Therapeutic product for renal anemia |
Business Area | Growth hormone |
Product Name | GROWJECT® |
Indication | Therapeutic product for growth hormone deficiency and short stature |
Business Area | Lysosomal disease |
Product Name | IZCARGO® |
Indication | Therapeutic product for Mucopolysaccharidosis type II |
Business Area | Lysosomal disease |
Product Name | Agalsidase Beta BS I.V. Infusion [JCR]※1 |
Indication | Therapeutic product for Fabry disease |
Business Area | Regenerative medical products |
Product Name | TEMCELL®HS Inj. |
Indication | Therapeutic product for acute graft-versus-host disease |
Business Area | Renal anemia |
Product Name | Epoetin Alfa BS Injection JCR ※2 |
Indication | Therapeutic product for renal anemia |
Business Area | Renal anemia |
Product Name | Darbepoetin Alfa BS Injection JCR ※2 |
Indication | Therapeutic product for renal anemia |
※1 These products are manufactured by JCR, while their medical information provision and marketing activities are handled by Sumitomo Pharma.
※2 These products are manufactured by JCR, while their medical information provision and marketing activities are handled by Kissei.